These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 34331342)
21. Characterization of two VQIXXK motifs for tau fibrillization in vitro. Li W; Lee VM Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091 [TBL] [Abstract][Full Text] [Related]
22. Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3. Ganguly P; Do TD; Larini L; LaPointe NE; Sercel AJ; Shade MF; Feinstein SC; Bowers MT; Shea JE J Phys Chem B; 2015 Apr; 119(13):4582-93. PubMed ID: 25775228 [TBL] [Abstract][Full Text] [Related]
23. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991 [TBL] [Abstract][Full Text] [Related]
24. Mapping the configurational landscape and aggregation phase behavior of the tau protein fragment PHF6. Pretti E; Shell MS Proc Natl Acad Sci U S A; 2023 Nov; 120(48):e2309995120. PubMed ID: 37983502 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of melatonin binding and destabilizing the protofilament and filament of tau R3-R4 domains revealed by molecular dynamics simulation. Zhu L; Gong Y; Lju H; Sun G; Zhang Q; Qian Z Phys Chem Chem Phys; 2021 Sep; 23(36):20615-20626. PubMed ID: 34514491 [TBL] [Abstract][Full Text] [Related]
26. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations. Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046 [TBL] [Abstract][Full Text] [Related]
27. Selection of a d-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice. Zhang X; Zhang X; Zhong M; Zhao P; Guo C; Li Y; Wang T; Gao H ACS Chem Neurosci; 2020 Dec; 11(24):4240-4253. PubMed ID: 33284003 [TBL] [Abstract][Full Text] [Related]
28. Pathogenic Mutation ΔK280 Promotes Hydrophobic Interactions Involving Microtubule-Binding Domain and Enhances Liquid-Liquid Phase Separation of Tau. Chen Y; Sun X; Tang Y; Tan Y; Guo C; Pan T; Zhang X; Luo J; Wei G Small; 2024 Oct; ():e2406429. PubMed ID: 39421885 [TBL] [Abstract][Full Text] [Related]
29. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity. Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481 [TBL] [Abstract][Full Text] [Related]
30. Formation and growth of oligomers: a Monte Carlo study of an amyloid tau fragment. Li DW; Mohanty S; Irbäck A; Huo S PLoS Comput Biol; 2008 Dec; 4(12):e1000238. PubMed ID: 19057640 [TBL] [Abstract][Full Text] [Related]
31. Secondary structures transition of tau protein with intrinsically disordered proteins specific force field. Dan A; Chen HF Chem Biol Drug Des; 2019 Mar; 93(3):242-253. PubMed ID: 30259679 [TBL] [Abstract][Full Text] [Related]
32. Alternative conformations of the Tau repeat domain in complex with an engineered binding protein. Grüning CSR; Mirecka EA; Klein AN; Mandelkow E; Willbold D; Marino SF; Stoldt M; Hoyer W J Biol Chem; 2014 Aug; 289(33):23209-23218. PubMed ID: 24966331 [TBL] [Abstract][Full Text] [Related]
33. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. von Bergen M; Barghorn S; Li L; Marx A; Biernat J; Mandelkow EM; Mandelkow E J Biol Chem; 2001 Dec; 276(51):48165-74. PubMed ID: 11606569 [TBL] [Abstract][Full Text] [Related]
34. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display. Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027 [TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulations reveal the destabilization mechanism of Alzheimer's disease-related tau R3-R4 Protofilament by norepinephrine. Wan J; Gong Y; Xu Z; Dong X; Wei G; Zhang Q Biophys Chem; 2021 Apr; 271():106541. PubMed ID: 33515860 [TBL] [Abstract][Full Text] [Related]
36. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer. Berhanu WM; Masunov AE J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402 [TBL] [Abstract][Full Text] [Related]
37. Conformational sampling with implicit solvent models: application to the PHF6 peptide in tau protein. Huang A; Stultz CM Biophys J; 2007 Jan; 92(1):34-45. PubMed ID: 17040986 [TBL] [Abstract][Full Text] [Related]
38. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils. Guru KrishnaKumar V; Baweja L; Ralhan K; Gupta S Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2590-2604. PubMed ID: 30071272 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid. Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571 [TBL] [Abstract][Full Text] [Related]
40. Charge-pairing mechanism of phosphorylation effect upon amyloid fibrillation of human tau core peptide. Inoue M; Hirata A; Tainaka K; Morii T; Konno T Biochemistry; 2008 Nov; 47(45):11847-57. PubMed ID: 18922026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]